MRK
vs
Merck & Co., Inc.
$123.78
BMY
Bristol-Myers Squibb Company
$62.37
Head-to-Head Comparison
| Metric | MRK | BMY |
|---|---|---|
| Market Cap | $235.0B | $115.0B |
| P/E Ratio | 12.0 | 8.0 |
| Div Yield | N/A | N/A |
| Sector | Healthcare | Healthcare |
| Beta | 0.30 | 0.29 |
| Revenue | N/A | N/A |
| Net Income | N/A | N/A |
| EPS | N/A | N/A |
Price Chart — MRK vs BMY
Loading chart...
→ Merck & Co., Inc. (MRK) Full Analysis
→ Bristol-Myers Squibb Company (BMY) Full Analysis
← Stock Screener
Disclaimer: Stock data sourced from Financial Modeling Prep, updated daily. Prices may be delayed. Interactive charts powered by TradingView. This page is for informational and educational purposes only and does not constitute investment advice. We are not licensed financial advisors. Please consult a qualified professional before making investment decisions.
Privacy Policy · Terms
Privacy Policy · Terms